Woldesenbet Selamawit A, Kufa Tendesayi, Barron Peter, Chirombo Brian C, Cheyip Mireille, Ayalew Kassahun, Lombard Carl, Manda Samuel, Diallo Karidia, Pillay Yogan, Puren Adrian J
Center for HIV and STI, National Institute for Communicable Diseases, Sandringham, Johannesburg.
School of Public Health, University of the Witwatersrand, Johannesburg.
AIDS. 2020 Mar 15;34(4):589-597. doi: 10.1097/QAD.0000000000002457.
To describe viral load levels among pregnant women and factors associated with failure to achieve viral suppression (viral load ≤50 copies/ml) during pregnancy.
Between 1 October and 15 November 2017, a cross-sectional survey was conducted among 15-49-year-old pregnant women attending antenatal care (ANC) at 1595 nationally representative public facilities.
Blood specimens were taken from each pregnant woman and tested for HIV. Viral load testing was done on all HIV-positive specimens. Demographic and clinical data were extracted from medical records or self-reported. Survey logistic regression examined factors associated with failure to achieve viral suppression.
Of 10 052 HIV-positive participants with viral load data, 56.2% were virally suppressed. Participants initiating antiretroviral therapy (ART) prior to pregnancy had higher viral suppression (71.0%) by their third trimester compared with participants initiating ART during pregnancy (59.3%). Booking for ANC during the third trimester vs. earlier: [adjusted odds ratio (AOR) 1.8, 95% confidence interval (CI):1.4-2.3], low frequency of ANC visits (AOR for 2 ANC visits vs. ≥4 ANC visits: 2.0, 95% CI:1.7-2.4), delayed initiation of ART (AOR for ART initiated at the second trimester vs. before pregnancy:2.2, 95% CI:1.8-2.7), and younger age (AOR for 15-24 vs. 35-49 years: 1.4, 95% CI:1.2-1.8) were associated with failure to achieve viral suppression during the third trimester.
Failure to achieve viral suppression was primarily associated with late ANC booking and late initiation of ART. Efforts to improve early ANC booking and early ART initiation in the general population would help improve viral suppression rates among pregnant women. In addition, the study found, despite initiating ART prior to pregnancy, more than one quarter of participants did not achieve viral suppression in their third trimester. This highlights the need to closely monitor viral load and strengthen counselling and support services for ART adherence.
描述孕妇的病毒载量水平以及与孕期未实现病毒抑制(病毒载量≤50拷贝/毫升)相关的因素。
2017年10月1日至11月15日期间,在全国1595家具有代表性的公共机构对年龄在15至49岁的产前检查(ANC)孕妇进行了横断面调查。
采集每位孕妇的血样并检测HIV。对所有HIV阳性样本进行病毒载量检测。从医疗记录或自我报告中提取人口统计学和临床数据。通过调查逻辑回归分析与未实现病毒抑制相关的因素。
在10052名有病毒载量数据的HIV阳性参与者中,56.2%实现了病毒抑制。与孕期开始抗逆转录病毒治疗(ART)的参与者(59.3%)相比,孕前开始ART的参与者在孕晚期病毒抑制率更高(71.0%)。孕晚期与更早进行ANC登记:[调整优势比(AOR)1.8,95%置信区间(CI):1.4 - 2.3],ANC就诊频率低(2次ANC就诊与≥4次ANC就诊的AOR:2.0,95%CI:1.7 - 2.4),ART开始延迟(孕中期开始ART与孕前开始的AOR:2.2,95%CI:1.8 - 2.7),以及年龄较小(15 - 24岁与35 - 49岁的AOR:1.4,95%CI:1.2 - 1.8)与孕晚期未实现病毒抑制相关。
未实现病毒抑制主要与ANC登记晚和ART开始晚有关。在普通人群中努力改善早期ANC登记和早期ART启动将有助于提高孕妇的病毒抑制率。此外,研究发现,尽管孕前开始ART,但超过四分之一的参与者在孕晚期未实现病毒抑制。这突出表明需要密切监测病毒载量并加强ART依从性的咨询和支持服务。